Final Report – July 2013
The Institute for Clinical and Economic Review
To make informed healthcare decisions, patients, clinicians, and policymakers need to consider many different kinds of information. Rigorous evidence on the comparative clinical risks and benefits of alternative care options is always important; but along with this information, decisionmakers must integrate other considerations. Patients and clinicians must weigh patients’ values and individual clinical needs. Payers and other policymakers must integrate information about current patterns of utilization, and the impact of any new policy on access, equity, and the overall functioning of systems of care. All decision-makers, at one level or another, must also consider the costs of care, and make judgments about how to gain the best value for every healthcare dollar.
The goal of this initiative is to provide a forum in which all these different strands of evidence, information, and public and private values can be discussed together, in a public and transparent process. Initially funded by a three-year grant from the federal Agency for Healthcare Research and Quality (AHRQ), and backed by a consortium of New England state policymakers, the mission of the New England Comparative Effectiveness Public Advisory Council (CEPAC) is to provide objective, independent guidance on how information on comparative effectiveness can best be used across New England to improve the quality and value of health care services. CEPAC is an independent body composed of clinicians and patient or public representatives from each New England state with skills in the interpretation and application of medical evidence in health care delivery. Representatives of state public health programs and of regional private payers are included as exofficio members of CEPAC. The latest information on CEPAC, including guidelines for submitting public comments, is available online: cepac.icer-review.org.
DOWNLOAD TO READ MORE
right click to open in a new tab